Cart
sales@molnova.com
BMS986188
CAS No. 1776115-10-6
BMS986188( —— )
Catalog No. M23793 CAS No. 1776115-10-6
BMS986188 is a novel Potent and Selective Positive Allosteric Modulator of the delta-Opioid Receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 41 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 133 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 288 | In Stock |
|
| 200MG | 403 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMS986188
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS986188 is a novel Potent and Selective Positive Allosteric Modulator of the delta-Opioid Receptor.
-
DescriptionBMS986188 is a novel Potent and Selective Positive Allosteric Modulator of the delta-Opioid Receptor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
Recptorδ-opioid receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1776115-10-6
-
Formula Weight535.47
-
Molecular FormulaC30H31BrO4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC1(CC2=C(C(C3=C(O2)CC(CC3=O)(C)C)C4=CC=C(C=C4)OCC5=CC=CC=C5Br)C(=O)C1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
AT-121 hydrochloride
AT-121 hydrochloride is a dual agonist of nociception and mu opioid receptor with Ki values of 3.67 and 16.49 nM, respectively.
-
[(pF)Phe4]Nociceptin...
Highly potent and selective nociceptin/orphanin FQ receptor (OP4) agonist peptide (pKi = 10.68; pEC50 = 9.80). Displays > 8000-fold selectivity over δ, κ, and μ opioid receptors and has relatively long lasting pronociceptive, hypotensive, negative inotropic and feeding stimulation effects in vivo.
-
Methylnaltrexone bro...
A peripherally-acting μ-opioid antagonist that acts to reverse some of the side effects of opioid drugs such as constipation without affecting analgesia or precipitating withdrawals.
